SUBSCRIBE

Breaking News on Contract Research, Manufacturing & Clinical Trials

Headlines > Clinical Development

2014: Year of the IPO and consolidation for CROs

22-Dec-2014 - With PRA and INC Research joining Parexel, Quintiles, Covance and Icon in the land of public companies, 2014 was a year in which the top shelf of CROs filled out.

PPD’s X-Chem licenses cardiovascular drug discovery program to Bayer

19-Dec-2014 - PPD’s biotech company X-Chem has licensed a second drug discovery program to Bayer Pharma, which follows on a multi-target collaboration the companies established in 2012. 

Cromos offers free clinical trials to cash-strapped small and mid-sized pharmas

18-Dec-2014 - Cromos Pharma has launched a free or reduced cost trial model to help small and mid-sized drugmakers overcome the funding Catch-22 that can derail development efforts.

Undeterred by Ukrainian unrest, KCR acquires portfolio of clinical projects

18-Dec-2014 - European CRO KCR has acquired a portfolio of clinical projects from the Ukrainian CRO Axis Group thereby making the country the most important location for KCR in the region of the Commonwealth...

CROs DaVita Clinical Research, HealthCare Partners Clinical Research to merge

17-Dec-2014 - CROs are consolidating further, this time with DaVita HealthCare Partners’ business units DaVita Clinical Research (DCR) and HealthCare Partners Clinical Research merging to further expand their services, specifically for patients with chronic kidney...

PPD partners with ERT to focus on big data collection

17-Dec-2014 - CROs Pharmaceutical Product Development (PPD) and ERT on Tuesday announced a strategic partnership to deliver ERT’s patient safety and efficacy endpoint data collection tools to help biopharma clients conduct clinical...

Cancer Treatment Centers of America selects WCG as IRB

16-Dec-2014 - Cancer Treatment Centers of America (CTCA) has selected the WIRB-Copernicus Group (WCG) to be its institutional review board (IRB) and thereby expand its clinical research program.

Covance says investor lawsuit seeking to derail LabCorp acquisition ‘without merit’

15-Dec-2014 - A Covance investor is raising questions over Goldman Sachs’ involvement in providing advice to the CRO’s board, which recently accepted a $6.1bn takeover offer from industry peer LabCorp.

CDSCO says Indian hospital charged for stem cell treatments given during unapproved trial

15-Dec-2014 - Indian regulators have accused a hospital of conducting unauthorised clinical trials of stem cell therapies and of charging patients who took part for the treatments.

Sweden hopes high-tech biomarker database will help trial recruitment

15-Dec-2014 - Sweden is an expert in high-tech trials but stalls in the recruitment phase, says the academic trying to change all that with a database of biomarkers matching patients to studies.

News in brief

WuXi to bolster US presence with Boston and San Francisco offices

15-Dec-2014 - WuXi PharmaTech is increasing its presence in the US announcing the opening of offices on the East and West coast.

Europe's response "disproportionate" says GVK Biosciences

15-Dec-2014 - GVK Biosciences has called marketing authorisation withdrawals by various European regulators “disproportionate,” arguing that ECG results at centre of data manipulation investigation have no bearing on safety.

Quintiles will continue to grow through acquisitions, says S&P

10-Dec-2014 - Quintiles has been upgraded to stable by ratings agency Standard & Poor after a second stock offering and the consolidation of debt through a $300m securitisation facility.

Medidata widening the gap on trial data competitors, say analysts

10-Dec-2014 - R&D investment and an integrated platform are widening the divide between Medidata and its competitors, according to analysts who are confident the trial data firm can achieve target sales of...

Analysts offer mostly positive outlook on PRA Health Sciences

09-Dec-2014 - A number of analysts recently initiated coverage on CRO PRA Health Sciences, with most predicting that the company’s recent IPO will result in a steadily growing stock price.

INC Research expands partnership with Society for Clinical Research Sites

08-Dec-2014 - INC Research has expanded its partnership with the Society for Clinical Research Sites (SCRS) through the end of 2015 to become the first organization to support SCRS' new member Scholarship...

Germany suspends drugs trialled by GVK Bio due to ongoing data falsification concerns

08-Dec-2014 - The EMA may withdraw marketing authorisation for generic drugs trialled by GVK Biosciences next month, after German regulators suspended several products and launched a review of alleged data manipulation by the...

CRO employee turnover rate falls as industry matures, survey finds

08-Dec-2014 - Over the last three years US turnover in clinical monitoring has dropped from 29.4% to 16.4% and globally overall company turnover has dropped from 27.2% to 14.2% on average, according...

Biorasi pushes into Western Europe with ABR acquisition

08-Dec-2014 - CRO Biorasi has acquired fellow CRO Advanced Biosciences Research (ABR) to expand its operations in the UK, Germany, Switzerland, and Sweden. 

CROs encouraged by new NIH policy calling for single IRB to speed trials

04-Dec-2014 - CRO industry group ACRO has welcomed a US NIH draft policy promoting use of a single IRB for site reviews per institute-backed multi-centre study, arguing that the approach would accelerate trials...

Parexel to bring in 450 laid-off GSK employees in North Carolina

03-Dec-2014 - GlaxoSmithKline is significantly reducing the size of its R&D team in the US, though about 450 of those employees who will be laid off in the Research Triangle Park (RTP),...

Two INDs or not two INDs? Unanswered questions in China draft MRCT guide

03-Dec-2014 - Drugmakers that include China in multi-regional trials will need to submit dossiers filed elsewhere for review, open up non-Chinese sites to CFDA inspection and consider additional local studies under draft...

Enrollment in Phase III study increases drastically following inVentiv dismissal

03-Dec-2014 - Cancer drug developer CEL-SCI announced Tuesday that since dropping CRO inVentiv Clinical back in 2013, patient enrollment in the trial run by its two new CRO partners – Aptiv Solutions...

Mabion extends agreement with Croatian CRO for Mabthera biosimilar study

01-Dec-2014 - The pace of recruitment is the biggest challenge in carrying out trials in Eastern Europe, says Mabion which has extended an agreement with local CRO Altiora for its biosimilar study.

Tracking Ebola difficult in countries where war has stunted healthcare development

01-Dec-2014 - Aid agencies in countries hardest hit by Ebola rely on manual, paper-based data collection according to one expert who says CDISC templates and mobile data capture would help.

Key Industry Events

 

Access all events listing

Our events, Events from partners...